Nestlé is recalling several batches of its SMA Infant Formula and Follow-On Formula as a precautionary measure due to the possible presence of cereulide toxin. Cereulide is a toxin produced by certain strains of Bacillus cereus and is highly heat-stable, meaning it is unlikely to be destroyed by boiling water or normal formula preparation processes; if consumed, it can lead to rapid onset symptoms such as nausea, vomiting, and abdominal cramps. The recall was first published on 5 January 2026 and updated on 6 January 2026 to improve formatting, with no new batches added to the list. The affected products include a wide range of SMA branded formula—such as SMA Advanced First Infant Milk (800g) with batch codes 51450742F1, 52319722BA and 52819722AA best before May 2027; SMA Advanced Follow-On Milk (800g) with multiple batch codes and best before dates from April to August 2027; SMA Anti Reflux (800g); SMA ALFAMINO (400g) with numerous batch codes and best before dates through 2027; various sizes of SMA First Infant Milk (400g, 800g, 1.2kg) with best before dates from November 2026 to October 2027; SMA LITTLE STEPS First Infant Milk (800g); SMA Comfort (800g); SMA First Infant Milk ready-to-feed formats (200ml and 70ml); and SMA Lactose Free (400g), all of which are detailed in the official alert. Company states that the possible presence of cereulide makes these products unsafe to consume, advising that even if no illness has been observed, consumers should stop using the recalled products immediately and consult a pharmacist or medical professional if the formula was prescribed by a healthcare provider. Nestlé has initiated the recall and will display point-of-sale notices in retail outlets explaining the action and what steps customers should take. Consumers who have purchased affected products are advised not to feed them to infants and to share a photo of the product and batch code via Nestlé’s online contact form or call the careline for a refund; those concerned about possible health effects following consumption should seek advice from healthcare professionals appropriate for their region.
Consumer News Region